Y-mAbs Therapeutics Inc (YMAB)
4.81
-0.15
(-3.02%)
USD |
NASDAQ |
Mar 28, 16:00
4.81
0.00 (0.00%)
After-Hours: 20:00
Y-mAbs Therapeutics Price to Book Value: 2.364 for March 28, 2025
View 4,000+ Financial Data Types:
Add
Browse
Price to Book Value Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Price to Book Ratio Definition
Price to book value is a valuation ratio that is measured by stock price / book value per share. The book value is essentially the tangible accounting value of a firm compared to the market value that is shown.
Price to Book Value Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Price to Book Value Benchmarks
| Apellis Pharmaceuticals Inc | 13.33 |
| Humacyte Inc | -- |
| NovaBay Pharmaceuticals Inc | 2.787 |
| Palatin Technologies Inc | -- |
| Theriva Biologics Inc | 0.1664 |
Price to Book Value Related Metrics
| PS Ratio | 2.432 |
| PEG Ratio | -0.1954 |
| Price | 4.81 |
| Earnings Yield | -13.93% |
| Market Cap | 217.50M |
| PEGY Ratio | -0.1954 |